The National Institutes of Health (NIH) hosted the Neuroscience Research Summit on Marijuana and Cannabinoids in March 2016. The Summit focused on the neurological and psychiatric effects of marijuana, other cannabinoids, and the endocannabinoid system.
The 25th Harm Reduction International Conference will take place in Montreal, Canada from May, 14th to May 17th, 2017. People who use drugs, sex workers, people living with HIV, researchers, campaigners, activists, health professionals, development specialists, human rights experts and others interested in harm reduction are invited to
The European College of Neuropsychopharmacology (ECNP) is a pan-European scientific association that encourages innovative research across the neurosciences and aims to translate new knowledge on fundamental disease mechanisms into new medicines and clinical applications. The annual ECNP Congress brings together neuroscientists, psychiatrists, neurologists and psyc
Substance misuse has a long reach into many medical specialties. Although substance misuse in patients has been managed primarily by psychiatrists, assessment and management of this should be a competency developed by all doctors. This event presents a selection of clinically relevant topics in substance misuse including:
This training course offers mental health nurses and other health-care professionals the opportunity to increase their knowledge and expand their skills when engaging with clients and families who use substances.
The 2016 Society for the Study of Addiction Annual (SSA) Symposium will focus on addiction and the scientific method. A vast range of speakers will present means to investigate, evaluate and conceptualise addictions across the board.
